FWP 1 fwp.htm FREE WRITING PROSPECTUS Unassociated Document
 
 
 

 
 
 
   
FREE WRITING PROSPECTUS
   
FILED PURSUANT TO RULE 433
   
REGISTRATION FILE NO.: 333-180779-01
     
 
 
NEW ISSUE CMBS:$1,123MM MORGAN STANLEY BofA MERRILL LYNCH SERIES 2012-C6
CO-LEAD MANAGERS & BOOKRUNNERS: MORGAN STANLEY & BofA MERRILL LYNCH
 
 CLASS    M/F    SIZE($MM)    CE(%)    WAL(YRS)    LAUNCH    TARGET PX
 A-1    Aaa/AAA    67.000    30.00%    2.55    25    100-
 A-2    Aaa/AAA    236.000    30.00%    4.87    50    103-
 A-3    Aaa/AAA    72.000    30.00%    7.49    80    103-
 A-4    Aaa/AAA    411.447    30.00%    9.81    85    103-
 A-S    Aaa/AAA    98.306    21.25%    9.91    145    103-
 B    Aa2/AA    50.557    16.75%    9.91    190    103-
 C    A2/A    43.536    12.88%    9.93    250    103-
 
PRICING SCHEDULED FOR 12:30
 
*** The depositor has filed a registration statement (including a prospectus) with the SEC (File Number 333-180779) for the offering to which this free writing prospectus relates.  Before you invest, you should read the prospectus in the registration statement and other documents the depositor has filed with the SEC for more complete information about the depositor, the issuing entity and this offering.  You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov.  Alternatively, the depositor, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling toll free 1-866-718-1649 or by email to prospectus@ms.com. ***
 
-------------------------------------------------------------------------------
 
Content prepared by sales/trading for institutions. NOT: research; independent/impartial; a recommendation or basis to consider MS a fiduciary or any type of advisor. Content changes without notice; is proprietary/indicative only (esp. prices, which are not for use by others); and is an invitation to consider a swap transaction under US CEA secs.1.71/23.605 (but not an offer to enter a transaction or buy/sell any instrument). MS may take conflicting actions, incl. trading before/after sending, market making, lending, advising or other services for instruments/issuers mentioned. Views may differ from others at MS; no representation of accuracy/completeness is made. Full terms at ms.com/disclaimers